Research output: Contribution to journal › Article › peer-review
The role of S-bond in tenoxicam keto-enolic tautomerization. / Arkhipov, Sergey G.; Sherin, Peter S.; Kiryutin, Alexey S. et al.
In: CrystEngComm, Vol. 21, No. 36, 28.09.2019, p. 5392-5401.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - The role of S-bond in tenoxicam keto-enolic tautomerization
AU - Arkhipov, Sergey G.
AU - Sherin, Peter S.
AU - Kiryutin, Alexey S.
AU - Lazarenko, Vladimir A.
AU - Tantardini, Christian
PY - 2019/9/28
Y1 - 2019/9/28
N2 - A non-steroidal anti-inflammatory drug, 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, called tenoxicam (TXM), with important implications in cancer treatment, has a peculiarity with respect to other molecules from the oxicam family. TXM is predominantly found in the zwitterionic form (ZWC) within the crystal structures of pure compounds and their solvates; however, it can be present in the β-keto-enolic form (BKE) or β-diketone (BDK) form. To understand this phenomenon, the combined effects of environment (solvent) and intra-molecular non-covalent interactions on the TXM keto-enol tautomerization were investigated through a combined experimental and computational study. We found that the polarity of a solvent had a minor influence on the crystallization process; this allowed to us synthesize and solve six new solvates with TXM in the ZWC form. Careful investigation of the non-covalent interactions between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) through a computational approach with the natural bond orbital (NBO) theory has shown that TXM crystallization is modulated by the S-bond. This study further confirms the importance of the S-bond in the drug design; however, nowadays, it is still underestimated.
AB - A non-steroidal anti-inflammatory drug, 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, called tenoxicam (TXM), with important implications in cancer treatment, has a peculiarity with respect to other molecules from the oxicam family. TXM is predominantly found in the zwitterionic form (ZWC) within the crystal structures of pure compounds and their solvates; however, it can be present in the β-keto-enolic form (BKE) or β-diketone (BDK) form. To understand this phenomenon, the combined effects of environment (solvent) and intra-molecular non-covalent interactions on the TXM keto-enol tautomerization were investigated through a combined experimental and computational study. We found that the polarity of a solvent had a minor influence on the crystallization process; this allowed to us synthesize and solve six new solvates with TXM in the ZWC form. Careful investigation of the non-covalent interactions between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) through a computational approach with the natural bond orbital (NBO) theory has shown that TXM crystallization is modulated by the S-bond. This study further confirms the importance of the S-bond in the drug design; however, nowadays, it is still underestimated.
KW - CRYSTAL-STRUCTURE
KW - CO-CRYSTALS
KW - MELOXICAM
KW - COCRYSTALS
KW - PHARMACOKINETICS
KW - SOLUBILITY
UR - http://www.scopus.com/inward/record.url?scp=85072305090&partnerID=8YFLogxK
U2 - 10.1039/c9ce00874h
DO - 10.1039/c9ce00874h
M3 - Article
AN - SCOPUS:85072305090
VL - 21
SP - 5392
EP - 5401
JO - CrystEngComm
JF - CrystEngComm
SN - 1466-8033
IS - 36
ER -
ID: 21609205